HER2 plays a critical role in cell proliferation and tumorigenesis; it has been widely studied in breast cancer as a poor prognostic factor and therapeutic target. Strong membrane positivity for HER2 was seen in 26 cases (76.47%) out of 34 cases of HGPUC. Here, ERBB2 is linked to breast carcinoma.